201 related articles for article (PubMed ID: 26694059)
1. Double-Layered Matrix of Shellac Wax-Lutrol in Controlled Dual Drug Release.
Phaechamud T; Choncheewa CE
AAPS PharmSciTech; 2016 Dec; 17(6):1326-1335. PubMed ID: 26694059
[TBL] [Abstract][Full Text] [Related]
2. Single and dual drug release patterns from shellac wax-lutrol matrix tablets fabricated with fusion and molding techniques.
Phaechamud T; Choncheewa C
Indian J Pharm Sci; 2015; 77(1):62-74. PubMed ID: 25767320
[TBL] [Abstract][Full Text] [Related]
3. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
[TBL] [Abstract][Full Text] [Related]
5. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
[TBL] [Abstract][Full Text] [Related]
6. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
7. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
Park JS; Shim JY; Park JS; Choi YW; Jeong SH
Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
[TBL] [Abstract][Full Text] [Related]
8. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
Raut Desai S; Rohera BD
Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
[TBL] [Abstract][Full Text] [Related]
9. Properties of gastroretentive sustained release tablets prepared by combination of melt/sublimation actions of L-menthol and penetration of molten polymers into tablets.
Fukuda M; Goto A
Chem Pharm Bull (Tokyo); 2011; 59(10):1221-6. PubMed ID: 21963630
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
Li CJ; Zhu JB; Yu WY
Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
[TBL] [Abstract][Full Text] [Related]
11. Bilayer Tablet Dissolution Kinetics Based on a Degassing Cyclic Flow UV-Vis Spectroscopy with Chemometrics.
Otsuka Y; Ito A; Takahashi T; Matsumura S; Takeuchi M; Tanaka H
Chem Pharm Bull (Tokyo); 2019; 67(4):361-366. PubMed ID: 30930440
[TBL] [Abstract][Full Text] [Related]
12. Influence of pH modifiers on the dissolution and stability of hydrochlorothiazide in the bi- and three-layer tablets.
Blatnik SU; Dreu R; Srčič S
Acta Pharm; 2015 Dec; 65(4):383-97. PubMed ID: 26677896
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine di-matrix depot tablets prepared by compression coating for obtaining zero-order release.
Liu T; Shi Y; Li J; Jiang W; Yin T; Zhang Y; He H; Wang Y; Tang X
Drug Dev Ind Pharm; 2018 Sep; 44(9):1426-1433. PubMed ID: 29871528
[TBL] [Abstract][Full Text] [Related]
14. Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis.
Mašková E; Kubová K; Vysloužil J; Pavloková S; Vetchý D
AAPS PharmSciTech; 2017 May; 18(4):1242-1253. PubMed ID: 27474035
[TBL] [Abstract][Full Text] [Related]
15. Controlled drug release of highly water-soluble pentoxifylline from time-limit disintegration-type wax matrix tablets.
Otsuka M; Matsuda Y
Pharm Res; 1994 Mar; 11(3):351-4. PubMed ID: 8008697
[TBL] [Abstract][Full Text] [Related]
16. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design.
Duque MD; Kreidel RN; Taqueda ME; Baby AR; Kaneko TM; Velasco MV; Consiglieri VO
Pharm Dev Technol; 2013; 18(5):1247-54. PubMed ID: 22670808
[TBL] [Abstract][Full Text] [Related]
17. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
Thakkar HP; Pancholi N; Patel CV
AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
[TBL] [Abstract][Full Text] [Related]
18. Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol.
Hong SI; Oh SY
Int J Pharm; 2008 May; 356(1-2):121-9. PubMed ID: 18272308
[TBL] [Abstract][Full Text] [Related]
19. Development of shellac-coated sustained release pellet formulations.
Farag Y; Leopold CS
Eur J Pharm Sci; 2011 Mar; 42(4):400-5. PubMed ID: 21251975
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical applications of shellac: moisture-protective and taste-masking coatings and extended-release matrix tablets.
Pearnchob N; Siepmann J; Bodmeier R
Drug Dev Ind Pharm; 2003 Sep; 29(8):925-38. PubMed ID: 14570313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
